Groups | Dose (mg/kg) | Before diabetes induction (0 day) | Blood Glucose Level (mg/dl) (After diabetes induction (14th day) | 14th Day | 28th Day |
Control | Vehicle | 59.50 ± 2.09 | 65.33 ± 1.76 | 68.33 ± 2.03 | 60.50 ± 1.87 |
Diabetic control | Vehicle | 81.78 ± 2.01a | 251.50 ± 1.29a | 272.00 ± 3.13a | 304.50 ± 2.04a |
HAFE | 100 | 70.50 ± 1.89 | 264.13 ± 1.70a | 157.00 ± 3.22b | 92.67 ± 2.41b |
HAFE | 200 | 62.50 ± 1.19 | 242.18 ± 5.02a | 155.17 ± 4.54b | 85.33 ± 3.51b,c |
HALE | 100 | 71.50 ± 2.09 | 264.13 ± 1.70a | 173.00 ± 3.22b | 96.17 ± 1.42b |
HALE | 200 | 63.50 ± 1.02 | 257.33 ± 1.04a | 163.17 ± 4.54b | 88.14 ± 3.51b,c |
Glibenclamide (Standard) | 5 | 61.00 ± 2.12 | 252.67 ± 8.71a | 142.83 ± 3.22b | 73.16 ± 1.57b,c |